These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Incidence and predictors of recurrent restenosis following implantation of drug-eluting stents for in-stent restenosis. Lee CW; Park CB; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ Catheter Cardiovasc Interv; 2007 Jan; 69(1):104-8. PubMed ID: 17139669 [TBL] [Abstract][Full Text] [Related]
26. Vessel size and outcome after coronary drug-eluting stent placement: results from a large cohort of patients treated with sirolimus- or paclitaxel-eluting stents. Elezi S; Dibra A; Mehilli J; Pache J; Wessely R; Schömig A; Kastrati A J Am Coll Cardiol; 2006 Oct; 48(7):1304-9. PubMed ID: 17010786 [TBL] [Abstract][Full Text] [Related]
27. Comparison of bare-metal and sirolimus- or paclitaxel-eluting stents for aorto-ostial coronary disease. Barlis P; Kaplan S; Dimopoulos K; Ferrante G; Di Mario C Cardiology; 2008; 111(4):270-6. PubMed ID: 18451644 [TBL] [Abstract][Full Text] [Related]
28. A comparison of mortality, myocardial infarction, and repeated revascularization for sirolimus-eluting and paclitaxel-eluting coronary stents. Hannan EL; Racz M; Holmes DR; Sharma S; Katz S; Walford G; King SB; Clark LT; Jones RH Am Heart J; 2007 Sep; 154(3):545-53. PubMed ID: 17719304 [TBL] [Abstract][Full Text] [Related]
29. Sirolimus-eluting stent showed better one-year outcomes than paclitaxel-eluting stent in a real life setting of coronary intervention in Koreans. Suh JW; Park JS; Cho HJ; Kim MS; Kang HJ; Cho YS; Koo BK; Chung WY; Youn TJ; Chae IH; Choi DJ; Kim HS; Sohn DW; Oh BH; Park YB Int J Cardiol; 2007 Apr; 117(1):31-6. PubMed ID: 17292498 [TBL] [Abstract][Full Text] [Related]
30. Drug-eluting stent implantation results in effective treatment of small coronary artery disease (DESIRE Small CAD). Mamkin I; Elkoustaf RA; Zhang Q; Mather JF; Kiernan FJ; McKay RG Conn Med; 2007 Oct; 71(9):517-22. PubMed ID: 17966720 [TBL] [Abstract][Full Text] [Related]
31. Antiproliferative agents alter vascular plasminogen activator inhibitor-1 expression: a potential prothrombotic mechanism of drug-eluting stents. Muldowney JA; Stringham JR; Levy SE; Gleaves LA; Eren M; Piana RN; Vaughan DE Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):400-6. PubMed ID: 17158352 [TBL] [Abstract][Full Text] [Related]
32. Inflation time and drug-eluting stent: the longer, the better.. Bertrand OF Catheter Cardiovasc Interv; 2009 Feb; 73(2):212-3. PubMed ID: 19156881 [No Abstract] [Full Text] [Related]
33. Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents. Kumar S; Suresh V; Prendergast BD; Brooks NH; Wicks P; Levy RD; Ray SG; Bennett DH; Lee HS Catheter Cardiovasc Interv; 2006 Nov; 68(5):663-8. PubMed ID: 17034063 [TBL] [Abstract][Full Text] [Related]
34. Patterns of restenosis after drug-eluting stent implantation: Insights from a contemporary and comparative analysis of sirolimus- and paclitaxel-eluting stents. Corbett SJ; Cosgrave J; Melzi G; Babic R; Biondi-Zoccai GG; Godino C; Morici N; Airoldi F; Michev I; Montorfano M; Sangiorgi GM; Bonizzoni E; Colombo A Eur Heart J; 2006 Oct; 27(19):2330-7. PubMed ID: 16952923 [TBL] [Abstract][Full Text] [Related]
35. Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries). Daemen J; Tanimoto S; García-García HM; Kukreja N; van de Sande M; Sianos G; de Jaegere PP; van Domburg RT; Serruys PW Am J Cardiol; 2007 Apr; 99(8):1027-32. PubMed ID: 17437722 [TBL] [Abstract][Full Text] [Related]
36. Safety of drug-eluting stents in the coronary artery in ST-elevation myocardial infarction at a single high-volume medical center. Bose R; Gupta G; Grayburn PA; Laible EA; Kang MJ; Choi JW Am J Cardiol; 2007 Sep; 100(6):949-52. PubMed ID: 17826375 [TBL] [Abstract][Full Text] [Related]
37. Two-year clinical outcome after coronary stenting of small vessels using 2.25-mm sirolimus- and paclitaxel-eluting stents: insight into the RESEARCH and T-SEARCH registries. Tanimoto S; Daemen J; Tsuchida K; García-García HM; de Jaegere P; van Domburg RT; Serruys PW Catheter Cardiovasc Interv; 2007 Jan; 69(1):94-103. PubMed ID: 17139687 [TBL] [Abstract][Full Text] [Related]
38. [Late stent thrombosis with drug eluting stents: disturbing signals on the radar]. Hansen PR Ugeskr Laeger; 2007 Apr; 169(17):1561-3. PubMed ID: 17484825 [TBL] [Abstract][Full Text] [Related]
39. Treatment of restenosis after bare-metal and drug-eluting stenting of an aorto-ostial lesion: challenges associated with excessive stent overhang. Kunadian B; Vijayalakshmi K; de Belder MA J Cardiovasc Med (Hagerstown); 2007 Sep; 8(9):744-7. PubMed ID: 17700411 [TBL] [Abstract][Full Text] [Related]
40. Long-term outcomes of bifurcation lesions after implantation of drug-eluting stents with the "mini-crush technique". Galassi AR; Colombo A; Buchbinder M; Grasso C; Tomasello SD; Ussia GP; Tamburino C Catheter Cardiovasc Interv; 2007 Jun; 69(7):976-83. PubMed ID: 17295334 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]